CAS: 110822-97-4; 2-(4H-1,2,4-Triazol-4-yl)Acetic Acid

该化合物是一个化学化合物,其特征为三联环结构,即五人组成的三联环化合物,含有三个氮原子;该化合物的特点是乙酸功能组,其作为碳盒酸衍生物的潜力有所增强;该化合物一般是白色的,是白色的,是非白色的固体;由于存在碳箱酸组,例如水和酒精等极溶剂中可溶解;三联可参与各种化学反应,使其成为有机合成和药用化学的多功能建筑块;该化合物的独特结构允许在制药,农用化学品和化学协调中的潜在应用;此外,该化合物可能展示生物活动,可在各种研究背景下加以探讨;与许多化学物质一样,应当谨慎处理,并遵循适当的安全议定书,以减少其使用所带来的任何风险.

结构式图片

相似化合物

66760-19-8 1204193-90-7 68984-21-4

欧盟法规

C&L通报

上下游产品

N,N-dimethylformamide azine dihydr°Chloride glycine diethyl 2-4H-1,2,4-triazol-4-ylmalonate N,N'-bis(dimethylaminomethylene)hydrazine

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2025091989-A1
    优先权日:2023-09-19
    标 题 :Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1055/s-2007-983896
    摘要:Garcia Y, Naik A, Marchand-Brynaert J. A Simplified Approach to N- and N,N′-Linked 1,2,4-Triazoles by Transamination. Synthesis. 2008 Jan;2008(1):149–54. doi: 10.1055/s-2007-983896.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知